We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$548M
AUM Growth
+$7.66M
Cap. Flow
-$12M
Cap. Flow %
-2.19%
Top 10 Hldgs %
32.65%
Holding
154
New
7
Increased
23
Reduced
102
Closed
2

Top Buys

Rank Stock Value
1
OTTR icon
Otter Tail
OTTR
+$3.75M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$2.15M
3
TEX icon
Terex
TEX
+$1.98M
4
ALTR
Altera Corp
ALTR
+$1.38M
5
CMC icon
Commercial Metals
CMC
+$1.25M

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$4.98M
2
STE icon
Steris
STE
+$4.1M
3
FCX icon
Freeport-McMoran
FCX
+$2.26M
4
ADI icon
Analog Devices
ADI
+$2.16M
5
JNJ icon
Johnson & Johnson
JNJ
+$1.91M

Sector Composition

Rank Sector Weight
1 Healthcare 24.56%
2 Industrials 19.03%
3 Technology 17.84%
4 Energy 9.49%
5 Utilities 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SU icon
126
Suncor Energy
SU
$77.6B
$480K 0.09%
11,262
-1,730
-13% -$67.4K
T icon
127
AT&T
T
$168B
$377K 0.07%
14,116
– –
CVD
128
DELISTED
COVANCE INC.
CVD
$367K 0.07%
4,290
-290
-6% -$25.8K
REGN icon
129
Regeneron Pharmaceuticals
REGN
$73.5B
$357K 0.07%
1,265
– –
COP icon
130
ConocoPhillips
COP
$144B
$323K 0.06%
3,767
– –
CHK
131
DELISTED
Chesapeake Energy Corporation
CHK
$310K 0.06%
56
– –
PGEN icon
132
Precigen
PGEN
$1.92B
$301K 0.06%
+12,518
New +$254K
WX
133
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
$273K 0.05%
8,322
-600
-7% -$20.5K
VZ icon
134
Verizon
VZ
$201B
$269K 0.05%
5,494
+200
+4% +$9.69K
ITT icon
135
ITT
ITT
$17.2B
$260K 0.05%
5,415
-1,200
-18% -$53.4K
ALLE icon
136
Allegion
ALLE
$13.5B
$246K 0.04%
4,348
-3,039
-41% -$160K
DGX icon
137
Quest Diagnostics
DGX
$26.2B
$246K 0.04%
4,200
– –
WFC icon
138
Wells Fargo
WFC
$258B
$226K 0.04%
4,306
– –
CIEN icon
139
Ciena
CIEN
$48.2B
$225K 0.04%
10,400
-150
-1% -$3.08K
TYG
140
Tortoise Energy Infrastructure Corp
TYG
$1.09B
$223K 0.04%
1,127
-150
-12% -$28.8K
CBU icon
141
Community Bank
CBU
$3.39B
$212K 0.04%
5,864
– –
STE icon
142
Steris
STE
$22.7B
$211K 0.04%
3,950
-79,700
-95% -$4.1M
VRSN icon
143
VeriSign
VRSN
$26B
$210K 0.04%
4,300
– –
VIAV icon
144
Viavi Solutions
VIAV
$8.15B
$156K 0.03%
21,975
– –
SVU
145
DELISTED
SUPERVALU Inc.
SVU
$82K 0.02%
1,429
– –
OCLR
146
DELISTED
Oclaro Inc.
OCLR
$81K 0.01%
36,975
– –
PBW icon
147
Invesco WilderHill Clean Energy ETF
PBW
$386M
$69K 0.01%
2,000
– –
EQU
148
DELISTED
EQUAL ENERGY LTD COM
EQU
$60K 0.01%
11,000
– –
AMD icon
149
Advanced Micro Devices
AMD
$708B
$42K 0.01%
10,000
– –
ACI
150
DELISTED
ARCH COAL, INC.
ACI
$42K 0.01%
1,150
– –
3 4 5
6
7

Similar funds

HCM
HMI Capital Management San Francisco, California $754M AUM 23.78% 1-Year Est. Return
FSCM
Front Street Capital Management Missoula, Montana $754M AUM 73.72% 1-Year Est. Return
SF
Symphony Financial Houston, Texas $755M AUM 25.99% 1-Year Est. Return
RMC
Resources Management Corp West Hartford, Connecticut $753M AUM 20.77% 1-Year Est. Return
BEC
Blue Edge Capital Richmond, Virginia $753M AUM 18.89% 1-Year Est. Return
GFM
GCQ Funds Management Sydney, Australia $753M AUM 2.76% 1-Year Est. Return
TPW
Talon Private Wealth The Villages, Florida $753M AUM
MWA
Meridian Wealth Advisors Austin, Texas $756M AUM 21.36% 1-Year Est. Return

John G. Ullman & Associates's Q2 2014 Portfolio in Review

As of Q2 2014, John G. Ullman & Associates held 154 positions worth $548M, up 1.4% from $540M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

John G. Ullman & Associates's Q2 2014 filing shows 7 new, 23 increased, 102 reduced and 2 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 47,646 shares worth $2.45M. The largest sale was Exelon, an estimated $4.98M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.

  • John G. Ullman & Associates's largest Q2 2014 buy was State Street SPDR S&P Biotech ETF: 47,646 shares worth $2.45M.
  • John G. Ullman & Associates added most to Otter Tail in Q2 2014, an estimated $3.75M increase.
  • John G. Ullman & Associates's biggest Q2 2014 reduction was Exelon, cutting an estimated $4.98M.
  • John G. Ullman & Associates fully exited Halliburton in Q2 2014, selling an estimated $707K.
  • John G. Ullman & Associates's ten largest holdings make up 33% of its $548M portfolio in Q2 2014.
  • John G. Ullman & Associates opened 7 new positions and closed 2 in Q2 2014.
  • John G. Ullman & Associates's portfolio value rose 1.4% quarter-over-quarter to $548M.

Based on John G. Ullman & Associates's 13F filing for Q2 2014, filed 18 Jul 2014.